Osteonecrosis of the Femoral Head

1. Comprehensive Introduction & Overview

Osteonecrosis of the femoral head (ONFH), also referred to as Avascular Necrosis (AVN) or aseptic necrosis, represents a debilitating orthopedic pathology characterized by the death of cellular components of the femoral head secondary to the interruption of its subchondral blood supply. Unlike traumatic fractures, ONFH is a progressive, insidious disease that often leads to subchondral bone collapse, secondary osteoarthritis, and permanent joint destruction if left untreated.

The femoral head is uniquely vulnerable due to its precarious blood supply, primarily provided by the medial circumflex femoral artery. When this microvascular circulation is compromised, the osteocytes, osteoblasts, and bone marrow cells undergo necrosis. This leads to a loss of structural integrity, eventually resulting in the mechanical failure of the weight-bearing surface. Clinically, this condition predominantly affects the young and active population, with a peak incidence in the third to fifth decades of life, making it a significant socio-economic burden.

2. Deep-Dive: Etiology and Pathophysiology

Etiology: The Multifactorial Nature

The etiology of ONFH is categorized into traumatic and non-traumatic causes. Traumatic cases typically involve femoral neck fractures or hip dislocations, which physically disrupt the retinacular vessels. Non-traumatic cases are more complex and involve systemic risk factors:

Pathophysiology: The Ischemic Cascade

The pathophysiology follows a predictable, albeit catastrophic, sequence:
1. Ischemia: Intravascular coagulation, fat embolism, or mechanical vessel compression leads to local hypoxia within the femoral head.
2. Cell Death: Osteocytes die within 6–12 hours, followed by marrow cell death within 24–48 hours.
3. Repair Response: The body attempts to revascularize the necrotic area. This "creeping substitution" involves the infiltration of granulation tissue.
4. Structural Failure: The repair process is often slower than the rate of bone resorption. The subchondral bone becomes weakened, leading to the "crescent sign" (a subchondral fracture) and eventual collapse of the articular surface.

3. Clinical Staging and Presentation

Standard Presentation

Patients typically present with deep, aching pain in the groin, buttock, or thigh. Initially, the pain is activity-related; as the disease progresses to collapse, pain becomes constant and is present during rest and at night. Reduced range of motion (ROM), particularly in internal rotation and abduction, is a hallmark physical finding.

The Ficat and Arlet Classification

This system remains the gold standard for clinical staging:

4. Differential Diagnosis

Distinguishing ONFH from other hip pathologies is critical for timely intervention. The following conditions must be ruled out:
* Transient Osteoporosis of the Hip: Usually resolves spontaneously; MRI shows diffuse edema without focal necrotic lesions.
* Hip Osteoarthritis: Characterized by joint space narrowing and marginal osteophytes; usually lacks the focal necrotic "ring" seen in AVN.
* Femoroacetabular Impingement (FAI): Mechanical pain with specific provocative maneuvers (FADIR/FABER).
* Labral Tears: Often present with mechanical locking or clicking; MRI arthrogram is diagnostic.
* Septic Arthritis: Acute onset, fever, elevated inflammatory markers (CRP/ESR).

5. Key Diagnostic Tests

Imaging Modalities

1. Radiographs (X-rays): Often normal in early stages. AP and Frog-leg lateral views are mandatory.
2. Magnetic Resonance Imaging (MRI): The gold standard for early detection (sensitivity >99%). Look for the "double-line sign" on T2-weighted images, representing the interface between necrotic bone and granulation tissue.
3. Computed Tomography (CT): Useful for assessing the extent of subchondral collapse and surgical planning in later stages.
4. Bone Scintigraphy: Rarely used now, but can show "cold" spots (avascular) or "hot" spots (reactive bone).

6. Clinical Management and Long-term Prognosis

Treatment Strategies

• Conservative (Limited Efficacy): Protected weight-bearing, bisphosphonates, and statins (in early stages). These rarely prevent progression but may delay it.
• Core Decompression: The gold standard for Stage I/II. Removing the necrotic core to reduce intraosseous pressure and promote revascularization.
• Bone Grafting: Vascularized or non-vascularized grafting to provide structural support.
• Osteotomy: Repositioning the necrotic area away from the primary weight-bearing axis (mostly in young patients).
• Total Hip Arthroplasty (THA): The definitive treatment for Stage III/IV or when pain/dysfunction is severe.

Prognosis

The prognosis is heavily dependent on the stage at diagnosis. Without intervention, more than 80% of patients with symptomatic femoral head necrosis will progress to collapse within two years. Post-operative outcomes for THA in AVN patients are generally excellent, though young patients face higher revision rates over their lifetime.

7. Risks and Contraindications

• Surgical Risks: Infection, venous thromboembolism (VTE), limb length discrepancy, and nerve palsy.
• Contraindications for Hip-Preserving Surgery: Severe articular collapse (Stage IV), advanced age, poor bone quality, and systemic comorbidities that preclude major surgery.

8. Massive FAQ Section

1. Is ONFH always bilateral?
It is bilateral in approximately 50–80% of cases. If diagnosed on one side, the contralateral hip must be screened with MRI.

2. Can lifestyle changes reverse AVN?
Lifestyle changes (stopping alcohol, smoking cessation) can prevent disease progression, but they cannot reverse bone death once it has occurred.

3. What is the "Crescent Sign"?
It is a radiolucent line beneath the articular cartilage, indicating a subchondral fracture. It marks the transition from pre-collapse to post-collapse.

4. Why is the femoral head so prone to this?
The blood supply is terminal and lacks significant collateral circulation, making it highly susceptible to ischemic insults.

5. How long does the recovery take after Core Decompression?
Usually 6 weeks of non-weight-bearing followed by 3–6 months of physical therapy.

6. Does steroid usage always cause AVN?
No, but high-dose, long-term usage significantly increases risk. The exact threshold dose is debated, but cumulative dose is a primary factor.

7. Is pain a reliable indicator of stage?
No. Many patients remain asymptomatic in Stage I and II, which is why screening high-risk patients is critical.

8. Can physical therapy cure ONFH?
Physical therapy cannot cure the necrotic process but is essential for maintaining range of motion and strengthening the abductor musculature.

9. What is the role of Bisphosphonates?
They are used to inhibit osteoclast activity, theoretically preventing the collapse of the femoral head by slowing bone resorption.

10. What is the success rate of Total Hip Arthroplasty for AVN?
Success rates are very high (>90% at 10 years), though the patient’s age is the primary predictor of long-term implant survival.

9. Conclusion

Osteonecrosis of the femoral head is a complex, progressive pathology that demands a high index of clinical suspicion. Early diagnosis via MRI and aggressive management, particularly in the pre-collapse stages, offer the best opportunity to preserve the native hip joint. For advanced disease, modern arthroplasty techniques provide reliable, pain-free outcomes, allowing patients to return to an active lifestyle. Clinical management must always be tailored to the patient’s age, activity level, and the specific stage of the disease.